《慢性胃炎中医诊疗专家共识(2023)》解读

Interpretation of Expert Consensus on Traditional Chinese Medicine Diagnosis and Treatment of Chronic Gastritis(2023)

慢性胃炎是临床常见病、高发病,近年来在多因素致病、幽门螺杆菌(Hp)感染及根除治疗的影响、内镜下病变的人工智能识别、中医病机认识、内镜局部辨证、中药复方疗效评价、高风险人群监测等方面不断取得进步。2023年12月,由中华中医药学会脾胃病分会制订的《慢性胃炎中医诊疗专家共识(2023)》于《中华中医药杂志》发表,该共识在2017版共识意见的基础上对慢性胃炎的中西医诊治进展进行了更新与完善,为临床医师规范诊治慢性胃炎提供了更新、更全面的指导。本文对该共识进行解读,以期加深理解,提高慢性胃炎的临床诊治水平。

Chronic gastritis is a common and high-incidence clinical disease.In recent years,progress has been continuously made in the pathogenesis of multifactorial causes,the effect of Helicobacter pylori(Hp)infection and its treatment on lesions,artificial intelligence identification of endoscopic lesions,traditional Chinese medicine recognition of pathogenesis,syndrome differentiation based on endoscopic findings,efficacy evaluation of Chinese medicine compound prescriptions,and monitoring of high-risk populations.In December 2023,the"Expert Consensus on the Traditional Chinese Medicine Diagnosis and Treatment of Chronic Gastritis(2023)"in formulated by the Spleen and Stomach Disease Branch of the Chinese Association of Chinese Medicine was published in the China Journal of Traditional Chinese Medicineand Pharmacy.Based on the consensus of 2017,the consensus updated and improved the progress of the diagnosis and treatment of chronic gastritis in both Chinese and Western medicine,in order to provided updated and more comprehensive guidance for clinicians to standardize the diagnosis and treatment of chronic gastritis.This article interprets the consensus in order to deepen understanding and improve the clinical diagnosis and treatment level of chronic gastritis.